| scholarly article | Q13442814 |
| P50 | author | Aleksandra Janas | Q60315842 |
| Joanna Folwarczna | Q60315847 | ||
| P2860 | cites work | Opioid analgesics and the risk of fractures in older adults with arthritis | Q24607425 |
| Fracture risk associated with the use of morphine and opiates | Q28219351 | ||
| Low bone density in patients receiving methadone maintenance treatment | Q33251399 | ||
| Relationship of opioid use and dosage levels to fractures in older chronic pain patients | Q33742530 | ||
| The management of chronic pain in important patient subgroups | Q34326675 | ||
| The effect of opioid therapy on endocrine function | Q34328078 | ||
| The comparative safety of opioids for nonmalignant pain in older adults | Q34625722 | ||
| Predictors of change in pain and physical functioning among post-menopausal women with recurrent pain conditions in the women's health initiative observational cohort | Q35645826 | ||
| Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). | Q50554046 | ||
| Bisphosphonate treatment may reduce osteoporosis risk in female cancer patients with morphine use: a population-based nested case-control study. | Q51266217 | ||
| Long-term fluoxetine administration does not result in major changes in bone architecture and strength in growing rats. | Q51773811 | ||
| Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. | Q51990035 | ||
| Loss of tolerance to morphine after a change in route of administration: control of within-session tolerance by interoceptive conditioned stimuli | Q60679025 | ||
| Bone status of senescent female rats: chemical, morphometric, and biomechanical analyses | Q68102190 | ||
| The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis | Q71549315 | ||
| Effects of chronic heroin abuse on bone and mineral metabolism | Q72880764 | ||
| Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist | Q73420669 | ||
| Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia | Q80136078 | ||
| Patients on injectable diacetylmorphine maintenance have low bone mass | Q83486093 | ||
| Preliminary study on the effect of parenteral naloxone, alone and in association with calcium gluconate, on bone healing in an ovine "drill hole" model system | Q35840233 | ||
| Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research | Q36134548 | ||
| Effects of Extracts from Trifolium medium L. and Trifolium pratense L. on Development of Estrogen Deficiency-Induced Osteoporosis in Rats | Q36473950 | ||
| "Safe and effective when used as directed": the case of chronic use of opioid analgesics | Q36549016 | ||
| The association of opioid use with incident lower extremity fractures in spinal cord injury. | Q36679731 | ||
| Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy | Q36893653 | ||
| Molecular mechanisms of opioid receptor-dependent signaling and behavior | Q36974487 | ||
| Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer | Q37247455 | ||
| The laboratory rat as an animal model for osteoporosis research | Q37253795 | ||
| Postoperative opioid administration inhibits bone healing in an animal model | Q37303297 | ||
| Opioid receptors and their ligands in the musculoskeletal system and relevance for pain control. | Q38085390 | ||
| Does opioid use for pain management warrant routine bone mass density screening in men? | Q38388182 | ||
| Evaluation of buprenorphine in a postoperative pain model in rats. | Q39306158 | ||
| Parathyroid hormone regulates osterix and Runx2 mRNA expression predominantly through protein kinase A signaling in osteoblast-like cells | Q40293414 | ||
| Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells | Q40706559 | ||
| Basic biomechanical measurements of bone: a tutorial | Q40797364 | ||
| Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. | Q40850250 | ||
| The effects of morphine on tissue structure of the growth plate in male rats | Q42060170 | ||
| The effect of morphine on orthodontic tooth movement in rats. | Q42774687 | ||
| Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by β-catenin stabilization. | Q43038767 | ||
| Decreased bone density in men on methadone maintenance therapy | Q43456156 | ||
| The endogenous opioid dynorphin is required for normal bone homeostasis in mice | Q44336388 | ||
| Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain | Q44336551 | ||
| Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database | Q44339247 | ||
| The role of opioid systems on orthodontic tooth movement in cholestatic rats | Q44339751 | ||
| Role of naloxone as an exogenous opioid receptor antagonist in spatial learning and memory of female rats during the estrous cycle | Q44341156 | ||
| Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10. | Q44348667 | ||
| Central nervous system active medications and risk for fractures in older women | Q44420332 | ||
| Intimate associations between the endogenous opiate systems and the growth hormone-releasing hormone system in the human hypothalamus | Q44882167 | ||
| Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats. | Q44933307 | ||
| Effects of natural phenolic acids on the skeletal system of ovariectomized rats. | Q45929747 | ||
| Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks. | Q46378694 | ||
| Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model | Q46846979 | ||
| Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene | Q46851682 | ||
| Endogenous opioids regulate alveolar bone loss in a periodontal disease model. | Q47673392 | ||
| Evaluation of osteoporosis risk associated with chronic use of morphine, fentanyl and tramadol in adult female rats | Q48209619 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoporosis | Q165328 |
| opioid | Q427523 | ||
| P304 | page(s) | 175-185 | |
| P577 | publication date | 2016-11-28 | |
| P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
| P1476 | title | Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis | |
| P478 | volume | 390 |
| Q89848783 | Amaranthus mangostanus Inhibits the Differentiation of Osteoclasts and Prevents Ovariectomy-Induced Bone Loss |
| Q90335957 | Influence of Pain and Analgesia on Orthopedic and Wound-healing Models in Rats and Mice |
| Q42262105 | Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis |
| Q55285080 | Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair. |
Search more.